Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Valvi, H. Muellerova, R. Tal-Singer, D. Mannino (Lexington, Upper Merion, United States Of America; London, United Kingdom). Fibrinogen and all-cause mortality in a nationally representative US cohort. Eur Respir J 2011; 38: Suppl. 55, 1018

Member's Comments

No comment yet.

Related content which might interest you: All-cause mortality in adults with incident asthma – a 20-year follow-up study of a large population-based cohort of middle-aged Danish adults Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019 The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 Clinical examination and all-cause mortality in non-mild COPD population – prospective study Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Predicting 12-month mortality in a Scottish COPD cohort Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Asthma and all-cause mortality in children and young adults - a Swedish population based study Source: International Congress 2019 – Early origins of respiratory diseases and later life consequences Year: 2019 Longitudinal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020 Year: 2021 Mortality risk in a Romanian cohort of patients hospitalised for COVID-19 Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 Trends in COPD mortality – Tales from the Swedish mortality register Source: Eur Respir J 2003; 22: Suppl. 45, 485s Year: 2003 Montelukast and the risk of major adverse cardiovascular events – a Danish population-based case-control study Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function Year: 2018 Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019 The glycemic gap and 90-day mortality in community-acquired pneumonia- A prospective cohort study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Sarcoidosis mortality in Sweden: a population-based cohort study Source: Eur Respir J, 51 (2) 1701815; 10.1183/13993003.01815-2017 Year: 2018 Sarcoidosis mortality in Sweden: a population-based cohort study Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Safety and risk factors for the morbidity and mortality of pneumonectomies: a retrospective 10-year study in a single institution Source: Virtual Congress 2020 – Thoracic surgery: malignancies Year: 2020 Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020